Acquisition to Include DANYELZA® (Naxitamab-gqgk), Further Broadening SERB’s Rare Oncology Product PortfolioTransaction Expands SERB’s Investment in the U.S.SERB to Commence…
VANCOUVER, BC / ACCESS Newswire / August 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE: BNXT)(OTC PINK:BNXTF)(FSE:BXT), a…
BEIJING, China, Aug. 4, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful…
VANCOUVER, BC / ACCESS Newswire / August 4, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased…
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,…
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,…
RALEIGH, N.C., Aug. 4, 2025 /PRNewswire/ -- Lumexa Imaging, one of the nation's largest providers of outpatient imaging services, today…
LONDON, UK and BUDAPEST, HUNGARY, Aug. 4, 2025 /PRNewswire/ -- Turbine, a leading developer of cell simulations with AI, today…
Expanding access to high-quality, physician-directed care in the northwest suburbs DOWNERS GROVE, IL / ACCESS Newswire / August 4, 2025…
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank…